Machine Learning for Biomedicine
ML4BM
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (4)
2023
-
Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas
Clinical Epigenetics, Vol. 15, Núm. 1
2021
-
Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation
Nature Genetics, Vol. 53, Núm. 9, pp. 1311-1321
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2017
-
Usefulness of transcriptional blood biomarkers as a non-invasive surrogate marker of mucosal healing and endoscopic response in ulcerative colitis
Journal of Crohn's and Colitis, Vol. 11, Núm. 11, pp. 1335-1346